My watch list
my.bionity.com  
Login  

WHO Disease Staging System for HIV Infection and Disease



WHO Disease Staging System for HIV Infection and Disease was first produced in 1990 by the World Health Organisation [1] and updated in September 2005. It is an approach for use in resource limited settings and is widely used in Africa and Asia and has been a useful research tool in studies of progression to symptomatic HIV disease. Most of these conditions are opportunistic infections that can be easily treated in healthy people. The staging system is different for adults and adolescents and children.

Additional recommended knowledge

Stage I: HIV disease is asymptomatic and not categorized as AIDS.

Stage II: include minor mucocutaneous manifestations and recurrent upper respiratory tract infections.

Stage III: includes unexplained chronic diarrhea for longer than a month, severe bacterial infections and pulmonary tuberculosis.

Stage IV: includes toxoplasmosis of the brain, candidiasis of the esophagus, trachea, bronchi or lungs and Kaposi's sarcoma; these diseases are used as indicators of AIDS.

See also

Notes

  1. ^ WHO (1990). "Interim proposal for a WHO Staging System for HIV infection and Disease.". Wkly Epidemiol Rec. 65 (29): 221-224. PubMed.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "WHO_Disease_Staging_System_for_HIV_Infection_and_Disease". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE